Home>APIs>

Atracurium Besylate

CAS number: 64228-81-5

Molecular formula: C53H72N2O12.2(C6H5O3S)

molecular weight: 1243.48

Chemical structure:

Producers shown on SFDA

(Record date:05/09/2021)

Producer

Documents

GMP Valid till(based on SFDA)

 Lianyungang Guike Pharmaceutical Co., Ltd.

GMP, DMF
Valid till August 2021

Jiangsu Shengdi Pharmaceutical Co., Ltd.

GMP 
Valid till February 2018

Jiangsu Hengrui Medicine Co.,Ltd.

GMP 
Valid till December 2022


Producers shown on EP

Not showing any


Producer:Lianyungang Guike Pharmaceutical Co., Ltd., established in 2006, is a high-tech integrated pharmaceutical manufacturer focuses on research, development, production and sales of pharmaceutical raw material. Located at No. 1 Xianfeng Road, Dapu Industrial Park, Lianyungang Economic and technological development zone,  and covers a total area of around 31148.9m2   with all facilities built strictly according to the GMP standard. The factory owns many internationally leading equipment imported from Europe and the United States. The products are popular for high quality and have customers in Japan, Korea, Russia, Belarus, Turkey, Pakistan, Indonesia, etc.

Staff size:50-99 people

Registered capital:RMB 43 million 23 thousand and 566


Producer:Founded in 2005, Jiangsu Shengdi Pharmaceutical Co., Ltd. is mainly engaged in the R & D and production of pharmaceutical raw materials, formerly known as the API branch of Jiangsu Hengrui Pharmaceutical Co., Ltd.

The company is now deregistered.

Staff size:/

Registered capital:RMB 50 million


Producer:Jiangsu Hengrui Medicine Co.,Ltd. is a pharmaceutical company engaged in the development and commercialization of innovative and high-quality drugs. 

The company has 28000 employees globally, fifth R & D centers were built around the globe and several subsidiaries were established in the US, EU, and Japan

The company has 10 manufacturing facilities and most of them maintain USP, EUP, and JP. We are the first Chinese company that exported injections on a large scale to the US, EU, and Japan markets. All dosage forms of the company have passed the national GMP certification, and ifosfamide, etoposide, mesilar and tiotepa have passed the verification of FDA.

Staff size:About 30000 people

Registered capital:RMB 6 billion 397 million


For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978